A Study to Evaluate the Effect of MK-5684 in Male Participants With Severe Renal Impairment (RI) and With End-stage Renal Disease (ESRD) (MK-5684-010)

Clinical trial NCT06814132 · COMPLETED

Trial details

NCT number: NCT06814132
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Kidney Failure, Chronic End-Stage Kidney Disease Renal Failure, Chronic Renal Failure, End-Stage Healthy Participants

Start date: 2025-04-07
Primary completion: 2025-10-04
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.